DD210034A5 - Verfahren zur herstellung von pirbuterol - Google Patents

Verfahren zur herstellung von pirbuterol Download PDF

Info

Publication number
DD210034A5
DD210034A5 DD82253605A DD25360582A DD210034A5 DD 210034 A5 DD210034 A5 DD 210034A5 DD 82253605 A DD82253605 A DD 82253605A DD 25360582 A DD25360582 A DD 25360582A DD 210034 A5 DD210034 A5 DD 210034A5
Authority
DD
German Democratic Republic
Prior art keywords
pirbuterol
solvolysis
preparation
hydrogenolysis
pyridine
Prior art date
Application number
DD82253605A
Other languages
German (de)
English (en)
Inventor
Jr Berkeley W Cue
Stephen S Massett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD210034A5 publication Critical patent/DD210034A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD82253605A 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol DD210034A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09

Publications (1)

Publication Number Publication Date
DD210034A5 true DD210034A5 (de) 1984-05-30

Family

ID=22875140

Family Applications (2)

Application Number Title Priority Date Filing Date
DD82253605A DD210034A5 (de) 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol
DD82237264A DD202544A5 (de) 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol und analoga

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD82237264A DD202544A5 (de) 1981-02-09 1982-02-08 Verfahren zur herstellung von pirbuterol und analoga

Country Status (26)

Country Link
EP (4) EP0058072A3 (ru)
JP (4) JPS57150665A (ru)
KR (1) KR860000623B1 (ru)
AR (4) AR231439A1 (ru)
AT (2) ATE20882T1 (ru)
AU (1) AU530826B2 (ru)
CA (1) CA1179677A (ru)
CS (1) CS229678B2 (ru)
DD (2) DD210034A5 (ru)
DE (2) DE3272793D1 (ru)
DK (1) DK157541C (ru)
EG (1) EG16242A (ru)
ES (4) ES509430A0 (ru)
FI (1) FI820396L (ru)
GR (1) GR75867B (ru)
GT (1) GT198273686A (ru)
IE (2) IE52325B1 (ru)
IL (1) IL64954A (ru)
NO (4) NO820371L (ru)
NZ (1) NZ199646A (ru)
PH (4) PH20622A (ru)
PL (4) PL130678B1 (ru)
PT (1) PT74397B (ru)
SU (4) SU1194273A3 (ru)
YU (3) YU42756B (ru)
ZA (1) ZA82778B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
JPS57150665A (en) 1982-09-17
DE3272061D1 (en) 1986-08-28
ATE20882T1 (de) 1986-08-15
IE52325B1 (en) 1987-09-16
EP0058071B1 (en) 1986-07-23
FI820396L (fi) 1982-08-10
PL130678B1 (en) 1984-08-31
JPS60208962A (ja) 1985-10-21
KR860000623B1 (ko) 1986-05-24
ES518973A0 (es) 1984-03-01
AU8027182A (en) 1982-08-19
SU1194273A3 (ru) 1985-11-23
PT74397B (en) 1984-10-09
PH20622A (en) 1987-03-06
ES518972A0 (es) 1984-03-01
PL130918B1 (en) 1984-09-29
GR75867B (ru) 1984-08-02
JPS6059911B2 (ja) 1985-12-27
YU26682A (en) 1985-04-30
PT74397A (en) 1982-03-01
EP0058071A2 (en) 1982-08-18
ES8403112A1 (es) 1984-03-01
NO824273L (no) 1982-08-10
IE820273L (en) 1982-08-09
YU201884A (en) 1985-04-30
IL64954A (en) 1986-03-31
JPS6135184B2 (ru) 1986-08-12
AR229373A1 (es) 1983-07-29
SU1240354A3 (ru) 1986-06-23
JPS6059231B2 (ja) 1985-12-24
EP0058072A3 (en) 1982-08-25
EP0058070A2 (en) 1982-08-18
DD202544A5 (de) 1983-09-21
DK52182A (da) 1982-09-17
EG16242A (en) 1989-01-30
CS229678B2 (en) 1984-06-18
JPS6119624B2 (ru) 1986-05-17
SU1217253A3 (ru) 1986-03-07
EP0058069A3 (en) 1982-09-01
ES518971A0 (es) 1984-03-01
AU530826B2 (en) 1983-07-28
EP0058071A3 (en) 1982-08-25
PL239426A1 (en) 1983-04-25
EP0058072A2 (en) 1982-08-18
DK157541B (da) 1990-01-22
PL130917B1 (en) 1984-09-29
NO824275L (no) 1982-08-10
YU201984A (en) 1985-04-30
EP0058069A2 (en) 1982-08-18
IE52326B1 (en) 1987-09-16
PL130580B1 (en) 1984-08-31
DE3272793D1 (en) 1986-10-02
PL239428A1 (en) 1983-04-25
JPS60208964A (ja) 1985-10-21
IL64954A0 (en) 1982-04-30
ES8403111A1 (es) 1984-03-01
AR229712A1 (es) 1983-10-31
GT198273686A (es) 1983-07-30
SU1250170A3 (ru) 1986-08-07
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
AR231439A1 (es) 1984-11-30
IE820275L (en) 1982-08-09
PH19164A (en) 1986-01-16
ES8403110A1 (es) 1984-03-01
NO820371L (no) 1982-08-10
ES8305721A1 (es) 1983-04-16
DK157541C (da) 1990-06-11
CA1179677A (en) 1984-12-18
PL239427A1 (en) 1983-04-25
NZ199646A (en) 1985-11-08
EP0058070A3 (en) 1982-08-25
YU42756B (en) 1988-12-31
ATE21691T1 (de) 1986-09-15
JPS6193164A (ja) 1986-05-12
EP0058069B1 (en) 1986-08-27
AR229374A1 (es) 1983-07-29
ES509430A0 (es) 1983-04-16
ZA82778B (en) 1983-01-26
KR830009028A (ko) 1983-12-17
PL235000A1 (en) 1983-04-11
NO824274L (no) 1982-08-10
PH19167A (en) 1986-01-16
PH20292A (en) 1986-11-18

Similar Documents

Publication Publication Date Title
DD202437A5 (de) Neue erythromycin a-verbindungen, verfahren zu ihrer herstellung sowie die verwendung der neuen verbindungen zur kontrolle von bakterien
EP0696575B1 (de) Verfahren zur Herstellung von optisch aktiven Amino-alkoholen
EP0153615B1 (de) Verfahren zur Herstellung von Tetronsäure
EP0847990A1 (de) 4-(C1-C4)-Alkoxy-3-pyrrolin-2-on-1-yl-essigsäuren, deren Herstellung und Verwendung zur Synthese von 4-Hydroxy-2-oxo-pyrrolidin-1-yl-acetamid
DD206371A5 (de) Verfahren zur herstellung eines 2s chiralen alkohols
DD210034A5 (de) Verfahren zur herstellung von pirbuterol
EP0569947A1 (de) Verfahren zur Herstellung von 2-Chlor-5-chlormethyl-pyridin
DE102006041941A1 (de) Verfahren zur Herstellung von 1,2-Diolen aus Carbonyl-Verbindungen
DE3325983A1 (de) Verfahren zur herstellung von tricyclo(5.2.1.0(pfeil hoch)2(pfeil hoch)(pfeil hoch),(pfeil hoch)(pfeil hoch)6(pfeil hoch))decan-2-carbonsaeure
DE1949793A1 (de) Neue Indanderivate und deren Herstellung
EP0171046B1 (de) Verfahren zur Herstellung von Pantolacton
EP1019356B1 (de) Verfahren zur herstellung von 3-hydroxy-2-methylbenzoesäure
EP0285109B1 (de) Verfahren zur Herstellung von 2-Amino-4-acylaminophenylethern
EP0542086B1 (de) Verfahren zur Herstellung von N-[(2-Chlor-pyridin-5-yl)methyl]-ethylendiamin
DE2034682A1 (de) Herstellung von eis 1 Propenylphos phonsaure
DE69929808T2 (de) Verfahren zur herstellung von 2-piperidinethanol-derivaten
DE2331044A1 (de) Diphenylmethan-derivate und verfahren zu deren herstellung
DE966024C (de) Verfahren zur Herstellung von Py-Tetrahydro-ª‰-carbolinen
DE963519C (de) Verfahren zur Herstellung von N, N'-Dibenzyl-aethylendiamin
DE2320285C2 (de) Verfahren zur Herstellung von Bicycloalkan-Carbonsäuren
DE2166997B2 (de) Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen
AT347473B (de) Verfahren zur herstellung von neuen morpholinverbindungen und deren nicht-toxischen salzen
DE3237605C2 (ru)
EP0492494B1 (de) Verfahren zur Herstellung von Procain
DE3903029A1 (de) Verfahren zur herstellung von 5-chlorpentanon-2